Related Experiment Video
Updated: Jul 8, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Acquired factor VIII inhibitor in a patient with dermatomyositis--a case study
Ayodele Ayoola1, Wajahath Mohsini, Sein Aung
1Department of Medicine, Franklin Square Hospital Center, Baltimore, MD 21237, USA. ayodeleayoola@hotmail.com
Background:
Acquired factor VIII inhibitor is an antibody formed against FVIII and seen in patients without FVIII replacement therapy. This entity has been associated with both autoimmune disease and infections.
Case Study:
We report the case of a 65-year-old man with dermatomyositis who presented with a bleeding episode following venipuncture and hematuria. His coagulation parameters were followed as well as the inhibitor level. His acquired FVIII inhibitor was managed successfully with rituximab.
Conclusion:
Our patient's bleeding episodes resolved and the inhibitor level was undetectable after 12 months. This is the first case of acquired FVIII inhibitor in association with dermatomyositis.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Therapeutic Drug Monitoring: Affecting Factors
Pericarditis III: Medical Management